Application 216608
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ARIPIPRAZOLE | ARIPIPRAZOLE | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 300MG/VIAL | No | No |
| 002 | ARIPIPRAZOLE | ARIPIPRAZOLE | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 400MG/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216608-001 | ARIPIPRAZOLE | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | ||
| A216608-002 | ARIPIPRAZOLE | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | AP | 2024-12-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | AP | 2024-12-03 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | AP | 2024-12-03 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | AP | 2024-12-03 | 2680178bc6a6… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216608-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216608-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216608-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216608-002 | AP | 1 | 2680178bc6a6… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aripiprazole | ARIPIPRAZOLE | Prefferred Pharmaceuticals Inc. | fbb3ac69-8dba-42df-8d6d-ef3d79241edb | 2025-01-03 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | NuCare Pharmaceuticals, Inc. | 27874fe2-3fd6-002d-e063-6294a90a4cd7 | 2024-11-22 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE ORALLY DISINTEGRATING | ScieGen Pharmaceuticals Inc | 4bcfd5a7-bec7-4426-9314-17daaf715cad | 2024-11-13 | Boxed warning, Warnings, Adverse reactions | Aripiprazole |
| aripiprazole | ARIPIPRAZOLE | Bryant Ranch Prepack | e7b6a156-8001-441c-bfd3-bf8987a339e8 | 2024-10-30 | Boxed warning, Warnings, Adverse reactions | aripiprazole ARIPIPRAZOLE |
| aripiprazole | ARIPIPRAZOLE | Bryant Ranch Prepack | b62837db-1949-4dba-9e2f-714a9f136f5a | 2024-10-29 | Boxed warning, Warnings, Adverse reactions | aripiprazole ARIPIPRAZOLE |
| aripiprazole | ARIPIPRAZOLE | Bryant Ranch Prepack | d130836c-5f1c-4779-ac6c-6350752dc015 | 2024-10-29 | Boxed warning, Warnings, Adverse reactions | aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | NCS HealthCare of KY, LLC dba Vangard Labs | d8183eaf-0093-4720-b8ed-20e570697511 | 2024-10-25 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | A-S Medication Solutions | bf3cf835-4c4e-47cb-be9c-bcb7c2e11cbe | 2024-10-16 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Aurobindo Pharma Limited | fcabd777-dcb7-452c-821c-575a5991c90a | 2024-10-03 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | VistaPharm, LLC | 06529caf-698f-41da-81ec-d0ba5ab200d7 | 2024-09-30 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Bryant Ranch Prepack | ee33be35-abc8-453f-98e9-7974026b7eb0 | 2024-08-22 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | A-S Medication Solutions | c8a94428-b6d2-428b-a3a5-7b983d572fab | 2024-06-05 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| aripiprazole | ARIPIPRAZOLE | A-S Medication Solutions | ab3973f3-3db8-4db2-8258-1b21af7b6380 | 2024-06-05 | Boxed warning, Warnings, Adverse reactions | aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | A-S Medication Solutions | 13339e7f-a8b4-430d-b623-47372de98348 | 2024-06-05 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | A-S Medication Solutions | 3ab6af7c-3169-46bf-bd3f-697c81bbcede | 2024-06-05 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| ARIPIPRAZOLE | ARIPIPRAZOLE | Solco Healthcare U.S., LLC | abb8ad7e-7998-4485-a09f-a2892190f4ad | 2024-04-23 | Boxed warning, Warnings, Adverse reactions | ARIPIPRAZOLE ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | A-S Medication Solutions | 89c2cddc-2ae3-4505-adf9-018542c713bf | 2024-04-11 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Bryant Ranch Prepack | 3c0109f6-0549-4f91-a259-d9d6d7329b91 | 2024-04-05 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Bryant Ranch Prepack | 6b0c3767-d397-4c7f-b229-083620d9ae6b | 2024-04-05 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE ORAL | NorthStar RxLLC | 4a0a2f6c-d7bb-48d1-b5ca-066f27f78e41 | 2024-04-04 | Boxed warning, Warnings, Adverse reactions | Aripiprazole |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 81193 | ORIG | 2025-02-10 |